Pilot study offers hope for leukemia patients blocked from standard care
NCT ID NCT06370000
Summary
This study is testing whether an oral medication can help prevent relapse in acute myeloid leukemia patients who are eligible for a stem cell transplant but cannot get one due to social or economic barriers. It will enroll 12 adult patients who have achieved remission but face challenges like financial hardship, lack of caregiver support, or limited healthcare access. The main goal is to see if patients can complete at least four cycles of this oral maintenance therapy safely.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Virginia Commonwealth University
RECRUITINGRichmond, Virginia, 23298, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.